New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 17, 2014
06:23 EDTQUREuniQure and Chiesi announce six year follow-up data from Glybera
uniQure and Chiesi Farmaceutici announced initial analysis of retrospectively collected individual patient data from LPLD patients treated with Glybera. The analysis covers follow-up data for up to six years post treatment for 13 patients, all of whom met indication requirements for the current labeling of Glybera in the EU. The review suggests that treatment with Glybera provides long-term beneficial effects with regard to the risk of encountering new pancreatitis events, including the occurrence of severe pancreatitis events. These results are in line with the trend exhibited in the first case note review performed up to 3 years after treatment with Glybera.
News For QURE From The Last 14 Days
Check below for free stories on QURE the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 2, 2014
05:50 EDTQUREuniQure focused on start of hemophilia B clinical trial in 2H14
Subscribe for More Information
05:49 EDTQUREuniQure signed distribution agreement with Medison Pharma
Subscribe for More Information
05:48 EDTQUREuniQure reports Q2 EPS (EUR 0.51) vs. (EUR 80) last year
Reports Q2 revenue EUR 1.04M vs. EUR 758,000 last year.
August 31, 2014
13:41 EDTQURECitigroup to hold a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use